{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T09:38:41Z","timestamp":1795081121213,"version":"4.10.2"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008271","name":"LEO Pharma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jtha.2025.10.020","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T01:43:50Z","timestamp":1762307030000},"page":"654-661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Outcomes of anticoagulation treatment for renal cell carcinoma tumor thrombi: a systematic review"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4700-0063","authenticated-orcid":false,"given":"Bram","family":"Akerboom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily S.L.","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur H.J.","family":"Kaptein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunenori","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"van der Hulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik J.","family":"van Gennep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri H.","family":"Versteeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thijs E.","family":"van Mens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9961-0754","authenticated-orcid":false,"given":"Frederikus A.","family":".Klok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 4","key":"10.1016\/j.jtha.2025.10.020_bib1","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0049-3848(09)70137-9","article-title":"Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model","volume":"123","author":"Sud","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.10.020_bib2","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.10.020_bib3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.020_bib4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","article-title":"Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline","volume":"34","author":"Falanga","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtha.2025.10.020_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/1076029618823288","article-title":"Influence of tumor thrombus on occurrence of distant venous thromboembolism and survival in patients with renal cell carcinoma after surgery","volume":"25","author":"Park","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.10.020_bib6","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/jth.12580","article-title":"The risk of venous thromboembolism in renal cell carcinoma patients with residual tumor thrombus","volume":"12","author":"Ihaddadene","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"Suppl 3","key":"10.1016\/j.jtha.2025.10.020_bib7","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.21037\/cdt.2017.09.16","article-title":"Tumor thrombus: incidence, imaging, prognosis and treatment","volume":"7","author":"Quencer","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.jtha.2025.10.020_bib8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","article-title":"Epidemiology of renal cell carcinoma: 2022 update","volume":"82","author":"Bukavina","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.jtha.2025.10.020_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/jth.12459","article-title":"Increased risk of preoperative venous thromboembolism in patients with renal cell carcinoma and tumor thrombus","volume":"12","author":"Yokom","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.020_bib10","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00000478-200305000-00005","article-title":"Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma","volume":"27","author":"Cheville","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jtha.2025.10.020_bib11","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/01.ju.0000045706.35470.1e","article-title":"Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy","volume":"169","author":"Zisman","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.jtha.2025.10.020_bib12","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.annonc.2024.05.537","article-title":"ESMO Guidelines Committee. Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"35","author":"Powles","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtha.2025.10.020_bib13","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2025.10.020_bib14","series-title":"SIGN 50: a guideline developer\u2019s handbook","year":"2014"},{"key":"10.1016\/j.jtha.2025.10.020_bib15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jvsv.2023.01.004","article-title":"Patency outcomes of primary inferior vena cava repair in radical nephrectomy and tumor thrombectomy","volume":"11","author":"Garg","year":"2023","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.jtha.2025.10.020_bib16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.urolonc.2004.02.001","article-title":"A contemporary evaluation of cytoreductive nephrectomy with tumor thrombus: morbidity and long-term survival","volume":"22","author":"Goetzl","year":"2004","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jtha.2025.10.020_bib17","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.juro.2008.10.036","article-title":"Intraoperative thrombus embolization during nephrectomy and tumor thrombectomy: critical analysis of the University of California-Los Angeles experience","volume":"181","author":"Shuch","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.jtha.2025.10.020_bib18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jvsv.2014.05.002","article-title":"Outcomes after inferior vena cava thrombectomy and reconstruction for advanced renal cell carcinoma with tumor thrombus","volume":"2","author":"Armstrong","year":"2014","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.jtha.2025.10.020_bib19","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s00268-015-2957-0","article-title":"Clinical outcomes related to the level of clamping in inferior vena cava surgery","volume":"39","author":"Jun","year":"2015","journal-title":"World J Surg"},{"key":"10.1016\/j.jtha.2025.10.020_bib20","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s11255-017-1583-1","article-title":"Fate of newly developed pulmonary embolism after surgery for renal cell carcinoma with vena cava thrombus","volume":"49","author":"Yoo","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.jtha.2025.10.020_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/JS9.0000000000000832","article-title":"Risk factors for incident venous thromboembolism in patients with renal tumor and inferior vena cava tumor thrombus: a retrospective case\u2013control study","volume":"110","author":"Wang","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/j.jtha.2025.10.020_bib22","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/jso.28020","article-title":"Late survival and long-term follow-up after radical resection of advanced renal cell carcinoma with associated venous tumor thrombus","volume":"131","author":"Chao","year":"2025","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jtha.2025.10.020_bib23","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/iju.14846","article-title":"\u201cThrombus-first\u201d or \u201cthrombus-last\u201d approach for surgical management of renal cell carcinoma with inferior vena cava thrombus","volume":"29","author":"Ishiyama","year":"2022","journal-title":"Int J Urol"},{"issue":"8 Pt B","key":"10.1016\/j.jtha.2025.10.020_bib24","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1053\/j.jvca.2022.04.023","article-title":"Perioperative outcomes for radical nephrectomy and level iii-iv inferior vena cava tumor thrombectomy in patients with renal cell carcinoma","volume":"36","author":"Vinzant","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtha.2025.10.020_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jtha.2024.10.002","article-title":"Management and outcomes in patients with tumor thrombus: a retrospective cohort study","volume":"23","author":"Hui","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.020_bib26","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jaccao.2022.07.011","article-title":"Prevalence, treatment, and prognosis of tumor thrombi in renal cell carcinoma","volume":"4","author":"Kaptein","year":"2022","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jtha.2025.10.020_bib27","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.020_bib28","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1111\/jth.15776","article-title":"Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease","volume":"20","author":"den Exter","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.020_bib29","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/jth.14564","article-title":"The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: guidance from the SSC of the ISTH","volume":"17","author":"Wang","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.020_bib30","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa1814630","article-title":"Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer","volume":"380","author":"Khorana","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.10.020_bib31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1814468","article-title":"Apixaban to prevent venous thromboembolism in patients with cancer","volume":"380","author":"Carrier","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.10.020_bib32","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1182\/blood-2010-02-270116","article-title":"Prediction of venous thromboembolism in cancer patients","volume":"116","author":"Ay","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.10.020_bib33","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3324\/haematol.2018.209114","article-title":"The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis","volume":"104","author":"Mulder","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.10.020_bib34","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa2416112","article-title":"Extended reduced-dose apixaban for cancer-associated venous thromboembolism","volume":"392","author":"Mah\u00e9","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.10.020_bib35","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.3390\/cancers15225382","article-title":"The role of anticoagulation in tumor thrombus associated with renal cell carcinoma: a literature review","volume":"15","author":"Williams","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"Suppl 1","key":"10.1016\/j.jtha.2025.10.020_bib36","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1182\/blood-2019-124476","article-title":"Natural history of tumor thrombus: a single-centre retrospective study","volume":"134","author":"Marcoux","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.10.020_bib37","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s11239-010-0519-8","article-title":"Pathophysiology, clinics and diagnostics of non-thrombotic pulmonary embolism","volume":"31","author":"Montagnana","year":"2011","journal-title":"J Thromb Thrombolysis"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625007202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625007202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:20:02Z","timestamp":1778224802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625007202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1538783625007202"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.10.020","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of anticoagulation treatment for renal cell carcinoma tumor thrombi: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}